News and analysis on disease research and diagnostics.
Singapore-MIT Research Alliance Developing Sample Prep, Dx Method for Low-Abundance Microorganisms
Researchers from the Singapore-MIT Alliance for Research and Technology has adapted a novel electrostatic microfilter to enhance detection of low concentrations of pathogens.
Invivoscribe, Complete Genomics Partner to Develop, Commercialize Oncology Biomarker Tests
The companies will collaborate to develop biomarkers tests for minimal residual disease (MRDs) in research and clinical setting using the DNBSeq sequencer.
Euroimmun Nabs CE Mark for Indirect Immunofluorescence Test Instrument
The firm said it is launching sales in countries that accept CE marking of its Uniqo 160 automated indirect immunofluorescence test instrument.
The firm received FDA 510(k) clearance late last year for its 10-minute blood-based test that stratifies patients by their risk of developing sepsis.
CMS Contractor Proposes Noncoverage of Castle Biosciences Skin Cancer Test
The contractor said that the test has not yet demonstrated definitive value above the combination of available clinical, pathological, and staging criteria in accurate risk stratification.